About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Boston | 649 Studies

Clinical Trials Lung CancerBoston

Lung Cancer Clinical Trials in Boston

Find 649 clinical trials for lung cancer near Boston, Massachusetts. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 649 trials

CompletedA Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsThe primary purpose of this study is to evaluate the efficacy of the study drug known as LY2875358, administered alone or in combination with a second drug named Erlotinib, in…NCT01900652·Birmingham, Alabama and 58 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as…NCT05786924·Gilbert, Arizona and 48 others

WithdrawnStudy of Proteins in Tumor Samples From Patients With Non-Small Cell Lung CancerThis research studies protein in tumor samples from patients with non-small cell lung cancer.NCT01415739·Boston, Massachusetts

CompletedA Study of INCAGN01876 in Participants With Advanced or Metastatic Solid TumorsThis was an open-label, non-randomized Phase 1/2 safety study of INCAGN01876 in participants with advanced or metastatic solid tumors that was conducted in 2 parts.NCT02697591·Los Angeles, California and 7 others

RecruitingA Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)NCT07361497·Daphne, Alabama and 258 others

Active not recruitingA Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerThis research study is studying a combination of two targeted therapies as a possible treatment for Non-Small Cell Lung Cancer (NSCLC) with an EGFR mutation.NCT03392246·Boston, Massachusetts and 3 others

CompletedGefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00411047·Boston, Massachusetts

Active not recruitingA Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLCA phase 3 study to demonstrate whether lorlatinib given as monotherapy is superior to crizotinib alone in prolonging the progression-free survival in advanced ALK-positive NSCLC…NCT03052608·Altamonte Springs, Florida and 165 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

CompletedPhase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFRThis research study is a Phase II clinical trial, which tests the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific cancer.NCT01854034·Boston, Massachusetts and 3 others

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

CompletedAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 in combination with TNO155 in patients with advanced solid…NCT04330664·Los Angeles, California and 16 others

CompletedA Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesThis is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and…NCT02571036·Scottsdale, Arizona and 25 others

RecruitingA Phase 1 Study of IM-1617 in Participants With Advanced CancerThis study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors.NCT07578571·New Haven, Connecticut and 4 others

CompletedSafety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted VaccineIn this study, Genocea is evaluating an investigational, personalized adjuvanted vaccine, GEN-009, that is being developed for the treatment of patients with solid tumors.NCT03633110·La Jolla, California and 10 others

Active not recruitingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a…NCT04625647·Birmingham, Alabama and 828 others

UnknownEMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerThis phase Ib/II trial studies the side effects and best dose of EMB-01 when given together with osimertinib in patients with EGFR-mutant non-small cell lung cancer that has…NCT05498389·Orange, California and 2 others

RecruitingStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsThis is a Phase 1/2A, open label, multicenter, nonrandomized, multiple dose, safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-07220060 administered as a…NCT04557449·Los Angeles, California and 38 others

Active not recruitingStudy of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsThis is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (also known as TSR-042) n…NCT02715284·Birmingham, Alabama and 127 others

PreviousPage 9 of 33Next

Other Conditions in Boston

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma